Vimarsana
Biggest News Aggregation in the World

Page 43 - Practice Guidelines News Today : Breaking News, Live Updates & Top Stories | Vimarsana

Stay updated with breaking news from Practice Guidelines. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.

Top News In Practice Guidelines Today - Breaking & Trending Today

Female health care workers need better protection from radiation, doctors say - Vimarsana News

Female health care workers need better protection from radiation, doctors say

Finnish study showed that breast cancer rates were 1.7 times higher than expected among radiologists, surgeons and cardiologists when compared to female physicians who don’t work with radiation. Finnish study showed that breast cancer rates were 1.7 times higher than expected among radiologists, surgeons and cardiologists when compared to female physicians who don’t work with…

NCCN collaborates with K Hospital and Vietnam Cancer Association to improve standards for cancer care - Vimarsana News

NCCN collaborates with K Hospital and Vietnam Cancer Association to improve standards for cancer care

He National Comprehensive Cancer Network-;a not-for-profit alliance of leading cancer centers in the United States-;today announced the signing of a Memo of Understanding (MOU) with Vietnam National Cancer Hospital ("K Hospital") and the Vietnam Cancer Association to work together to improve standards for cancer care throughout the country.

Novartis Pharma AG: Novartis Kisqali® significantly reduced the risk of recurrence by 25% across a broad population of patients with early breast cancer; clinically meaningful benefit was consistent across subgroups - Vimarsana News

Novartis Pharma AG: Novartis Kisqali® significantly reduced the risk of recurrence by 25% across a broad population of patients with early breast cancer; clinically meaningful benefit was consistent across subgroups

Kisqali is the first and only CDK4/6 inhibitor to demonstrate a consistent, clinically meaningful benefit across a broad population of patients with HR+/HER2- early breast cancer, regardless of disease

Novartis Kisqali® significantly reduced the risk of recurrence by 25% across a broad population of patients with early breast cancer; clinically meaningful benefit was consistent across subgroups - Vimarsana News

Novartis Kisqali® significantly reduced the risk of recurrence by 25% across a broad population of patients with early breast cancer; clinically meaningful benefit was consistent across subgroups

Kisqali is the first and only CDK4/6 inhibitor to demonstrate a consistent, clinically meaningful benefit across a broad population of patients with HR+/HER2-...

Female health care workers need better protection from radiation, doctors say - Vimarsana News

Female health care workers need better protection from radiation, doctors say

A group of physicians is calling on health care employers to provide female workers who are exposed to on-the-job radiation with added protections to minimize their risk of breast cancer.